Seite 2 von 196
Neuester Beitrag: 03.07.14 16:03
|Eröffnet am:||19.09.11 13:39||von: steven-bln||Anzahl Beiträge:||5.875|
|Neuester Beitrag:||03.07.14 16:03||von: AriadFrust||Leser gesamt:||348.126|
|Seite: < 1 | | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... 196 >|
6. Ariad Pharmaceuticals Inc. (ARIA): Focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. Market cap of $1.75B. On 12/09/2011, Barclays Capital had an Overweight rating on the stock. The stock is a short squeeze candidate, with a short float at 10.98% (equivalent to 5.14 days of average volume). The stock has had a couple of great days, gaining 12.22% over the last week.
ARIAD to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 2, 2012-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company’s business at two upcoming investor conferences:
The 14th Annual BIO CEO & Investor Conference in New York City. Dr. Berger’s presentation is on Monday, February 13 at 9:00 a.m. (ET)
The Leerink Swann 2012 Global Healthcare Conference in New York City. Dr. Berger’s presentation is on Wednesday February 15 at 3:30 p.m. (ET)
Both presentations will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the presentation will also be available and archived on the site for three weeks.
sicherlich haben wir Beide ein fantastisches + auf der Haben Seite - jetzt Gewinn einfahren ist bestimmt eine gute Idee..............
laufen lassen? Ich lasse noch laufen.............unter strengster Beobachtung und Stopp
aktuellste Meldung -
Furthermore, HealthCor also added a new $24 million position in Ariad Pharmaceuticals Inc. (ARIA), that is engaged in the development of drugs that treat aggressive and advanced-stage cancer by regulating cell signaling with small molecules.
Q 1 Zahlen nebenbei <, morgen
ARIAD Pharmaceuticals, Inc. has added a news release to its Investor Relations website.
Title: ARIAD to Webcast Conference Call on First Quarter 2012 Financial Results
Date(s): 25-Apr-2012 7:36 AM
For a complete listing of our news releases, please click here
CAMBRIDGE, Mass., Apr 25, 2012 (BUSINESS WIRE) --ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
host a live webcast of its quarterly conference call at 8:30 a.m. (ET)
on Wednesday, May 9, 2012. Harvey J. Berger, M.D., chairman and chief
executive officer, will host the call. ARIAD senior management will
discuss the Company's financial results as of March, 31, 2012, as well
as key corporate objectives and additional corporate activities. The
Company will announce highlights of these topics in a press release to
be issued before the market opens on May 9, 2012 prior to the conference
The live webcast can be accessed by visiting the investor relations
section of the Company's website at http://investor.ariad.com.
The call can be accessed by dialing 800-260-8140 (domestic) or 617
-614-3672 (international) five minutes prior to the start time and
providing the pass code 33704570. A replay of the call will be available
on the ARIAD website approximately two hours after completion of the
call and will be archived for three weeks.
und ich lasse laufen und ziehe meinen Stopp in Ruhe Stück für Stück nach